FFAS03 list of results H.sapiens / PfamA26U

Shows best template from each database, and all templates with significant scores covering different query fragments

Results: 1-20 of 55674 next page >

# Query Length Result vs. Range Score %id Covered by template(s)
1 sp|Q29940|1B59_HUMAN(removed signalp:1-24) HLA class I histocompatibility antigen, B-59 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1 338 PfamA26U 1-179 -97.800 79 PF00129.13; 1A01_SAGOE/25-203; Class I Histocompatibility antigen, domains alpha 1 and 2
43-311 -15.100 13 PF02124.10; Q8JMQ7_9ALPH/202-414; Marek`s disease glycoprotein A
190-271 -32.000 25 PF07654.10; IGHG3_MOUSE/234-320; Immunoglobulin C1-set domain
2 sp|P08908|5HT1A_HUMAN 5-hydroxytryptamine receptor 1A OS=Homo sapiens GN=HTR1A PE=1 SV=3 422 PfamA26U 38-418 -31.300 11 PF10321.4; Q9N526_CAEEL/3-311; Serpentine type 7TM GPCR chemoreceptor Srt
53-400 -94.900 36 PF00001.16; HRH2_CANFA/35-288; 7 transmembrane receptor (rhodopsin family)
3 sp|Q15758|AAAT_HUMAN Neutral amino acid transporter B(0) OS=Homo sapiens GN=SLC1A5 PE=1 SV=2 541 PfamA26U 54-485 -68.900 17 PF00375.13; A4CFF6_9GAMM/3-377; Sodium:dicarboxylate symporter family
4 sp|P61221|ABCE1_HUMAN ATP-binding cassette sub-family E member 1 OS=Homo sapiens GN=ABCE1 PE=1 SV=1 599 PfamA26U 7-37 -9.720 77 PF04068.10; A3FQC8_CRYPV/19-50; Possible Fer4-like domain in RNase L inhibitor, RLI
70-525 -14.500 9 PF13175.1; A9A6W0_METM6/4-391; AAA ATPase domain
94-597 -14.200 9 PF07088.6; GVPD1_HALSA/23-536; GvpD gas vesicle protein
117-245 -24.700 15 PF00005.22; YTFR_ECOLI/49-174; ABC transporter
117-542 -23.000 10 PF09818.4; Q2C6W1_9GAMM/1-438; Predicted ATPase of the ABC class
5 sp|P07108|ACBP_HUMAN Acyl-CoA-binding protein OS=Homo sapiens GN=DBI PE=1 SV=2 87 PfamA26U 3-86 -58.100 46 PF00887.14; ACBP6_ARATH/3-87; Acyl CoA binding protein
6 sp|O15254|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens GN=ACOX3 PE=1 SV=2 (Range:1-300) 300 PfamA26U 33-274 -20.400 9 PF11794.3; A3K7D3_9RHOB/13-275; 4-hydroxyphenylacetate 3-hydroxylase N terminal
7 sp|O15254|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens GN=ACOX3 PE=1 SV=2 (Range:151-450) 300 PfamA26U 1-124 -16.100 12 PF11794.3; A3K7D3_9RHOB/13-275; 4-hydroxyphenylacetate 3-hydroxylase N terminal
144-300 -29.300 17 PF00441.19; O33331_MYCTU/253-403; Acyl-CoA dehydrogenase, C-terminal domain
8 sp|O15254|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens GN=ACOX3 PE=1 SV=2 (Range:301-600) 300 PfamA26U 1-166 -34.200 19 PF00441.19; O33331_MYCTU/253-403; Acyl-CoA dehydrogenase, C-terminal domain
210-300 -21.900 15 PF01756.14; O62140_CAEEL/484-669; Acyl-CoA oxidase
9 sp|O15254|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens GN=ACOX3 PE=1 SV=2 (Range:451-700) 250 PfamA26U 60-246 -69.400 18 PF01756.14; O62140_CAEEL/484-669; Acyl-CoA oxidase
10 sp|Q9H013|ADA19_HUMAN(removed signalp:1-25) Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 (Range:1-300) 300 PfamA26U 2-137 -51.700 23 PF01562.14; ATS3_HUMAN/42-201; Reprolysin family propeptide
185-300 -55.800 24 PF01421.14; ADAM2_BOVIN/178-375; Reprolysin (M12B) family zinc metalloprotease
11 sp|Q9H013|ADA19_HUMAN(removed signalp:1-25) Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 (Range:151-450) 300 PfamA26U 35-233 -78.900 24 PF01421.14; ADAM2_BOVIN/178-375; Reprolysin (M12B) family zinc metalloprotease
250-300 -23.000 45 PF00200.18; ADA32_HUMAN/400-477; Disintegrin
12 sp|Q9H013|ADA19_HUMAN(removed signalp:1-25) Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 (Range:301-600) 300 PfamA26U 1-83 -29.600 22 PF01421.14; ADAM2_BOVIN/178-375; Reprolysin (M12B) family zinc metalloprotease
100-175 -30.300 42 PF00200.18; ADA32_HUMAN/400-477; Disintegrin
177-294 -37.300 25 PF08516.7; ADAM2_MACFA/473-589; ADAM cysteine-rich
13 sp|Q9H013|ADA19_HUMAN(removed signalp:1-25) Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 (Range:451-750) 300 PfamA26U 1-254 -11.600 15 PF07243.6; GP_PTPV/282-808; Phlebovirus glycoprotein G1
27-142 -26.400 25 PF08516.7; ADAM2_MACFA/473-589; ADAM cysteine-rich
38-241 -13.200 12 PF06247.6; Q968Z9_9APIC/23-221; Plasmodium ookinete surface protein Pvs28
137-300 -11.600 16 PF13908.1; Q6DC69_DANRE/23-231; Wnt and FGF inhibitory regulator
152-206 -13.900 21 PF01414.14; JAG2_RAT/132-194; Delta serrate ligand
14 sp|Q9H013|ADA19_HUMAN(removed signalp:1-25) Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 (Range:601-900) 300 PfamA26U 4-48 -11.600 20 PF04885.8; Q40579_TOBAC/7-146; Stigma-specific protein, Stig1
31-299 -11.000 10 PF00513.13; VL2_HPV56/5-455; Late Protein L2
82-300 -14.100 8 PF05934.6; CLCC1_HUMAN/3-551; Mid-1-related chloride channel (MCLC)
15 sp|Q9H013|ADA19_HUMAN(removed signalp:1-25) Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 (Range:751-930) 180 PfamA26U 1-180 -18.200 8 PF11725.3; A8E3E7_PSEVI/1-1719; Pathogenicity factor
16 sp|P11766|ADHX_HUMAN Alcohol dehydrogenase class-3 OS=Homo sapiens GN=ADH5 PE=1 SV=4 374 PfamA26U 32-160 -35.300 23 PF08240.7; Q92UI4_RHIME/24-130; Alcohol dehydrogenase GroES-like domain
202-333 -27.400 21 PF00107.21; ADH_SULSO/182-311; Zinc-binding dehydrogenase
17 sp|Q99490|AGAP2_HUMAN Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 (Range:1-300) 300 PfamA26U 1-207 -13.600 11 PF05782.6; ECM1_HUMAN/1-540; Extracellular matrix protein 1 (ECM1)
2-300 -13.300 9 PF03344.10; A7KII2_SALSA/6-727; Daxx Family
18 sp|Q99490|AGAP2_HUMAN Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 (Range:151-450) 300 PfamA26U 5-295 -11.400 12 PF11725.3; A8E3E7_PSEVI/1-1719; Pathogenicity factor
9-213 -11.800 9 PF05782.6; ECM1_HUMAN/1-540; Extracellular matrix protein 1 (ECM1)
19 sp|Q99490|AGAP2_HUMAN Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 (Range:301-600) 300 PfamA26U 62-274 -16.100 10 PF05783.6; Q561T1_DANRE/5-493; Dynein light intermediate chain (DLIC)
108-268 -54.400 28 PF00071.17; RAB9A_CANFA/9-174; Ras family
20 sp|Q99490|AGAP2_HUMAN Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 (Range:451-750) 300 PfamA26U 1-118 -44.600 25 PF00071.17; RAB9A_CANFA/9-174; Ras family
183-284 -9.890 10 PF00373.13; Q4T8R8_TETNG/88-414; FERM central domain

FFAS is supported by the NIH grant R01-GM087218-01

jobs submitted since Jan 1, 2011

Comments and questions to: webmaster

#	Query	Length	Result vs.	Range	Score	%id	Covered by template(s)
1	`sp\|Q29940\|1B59_HUMAN(removed signalp:1-24) HLA class I histocompatibility antigen, B-59 alpha chain OS=Homo sapiens GN=HLA-B PE=2 SV=1`	`338`	`PfamA26U`	`1-179`	`-97.800`	`79`	`PF00129.13; 1A01_SAGOE/25-203; Class I Histocompatibility antigen, domains alpha 1 and 2`
				`43-311`	`-15.100`	`13`	PF02124.10; Q8JMQ7_9ALPH/202-414; Marek`s disease glycoprotein A
				`190-271`	`-32.000`	`25`	`PF07654.10; IGHG3_MOUSE/234-320; Immunoglobulin C1-set domain`
2	`sp\|P08908\|5HT1A_HUMAN 5-hydroxytryptamine receptor 1A OS=Homo sapiens GN=HTR1A PE=1 SV=3`	`422`	`PfamA26U`	`38-418`	`-31.300`	`11`	`PF10321.4; Q9N526_CAEEL/3-311; Serpentine type 7TM GPCR chemoreceptor Srt`
				`53-400`	`-94.900`	`36`	`PF00001.16; HRH2_CANFA/35-288; 7 transmembrane receptor (rhodopsin family)`
3	`sp\|Q15758\|AAAT_HUMAN Neutral amino acid transporter B(0) OS=Homo sapiens GN=SLC1A5 PE=1 SV=2`	`541`	`PfamA26U`	`54-485`	`-68.900`	`17`	`PF00375.13; A4CFF6_9GAMM/3-377; Sodium:dicarboxylate symporter family`
4	`sp\|P61221\|ABCE1_HUMAN ATP-binding cassette sub-family E member 1 OS=Homo sapiens GN=ABCE1 PE=1 SV=1`	`599`	`PfamA26U`	`7-37`	`-9.720`	`77`	`PF04068.10; A3FQC8_CRYPV/19-50; Possible Fer4-like domain in RNase L inhibitor, RLI`
				`70-525`	`-14.500`	`9`	`PF13175.1; A9A6W0_METM6/4-391; AAA ATPase domain`
				`94-597`	`-14.200`	`9`	`PF07088.6; GVPD1_HALSA/23-536; GvpD gas vesicle protein`
				`117-245`	`-24.700`	`15`	`PF00005.22; YTFR_ECOLI/49-174; ABC transporter`
				`117-542`	`-23.000`	`10`	`PF09818.4; Q2C6W1_9GAMM/1-438; Predicted ATPase of the ABC class`
5	`sp\|P07108\|ACBP_HUMAN Acyl-CoA-binding protein OS=Homo sapiens GN=DBI PE=1 SV=2`	`87`	`PfamA26U`	`3-86`	`-58.100`	`46`	`PF00887.14; ACBP6_ARATH/3-87; Acyl CoA binding protein`
6	`sp\|O15254\|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens GN=ACOX3 PE=1 SV=2 (Range:1-300)`	`300`	`PfamA26U`	`33-274`	`-20.400`	`9`	`PF11794.3; A3K7D3_9RHOB/13-275; 4-hydroxyphenylacetate 3-hydroxylase N terminal`
7	`sp\|O15254\|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens GN=ACOX3 PE=1 SV=2 (Range:151-450)`	`300`	`PfamA26U`	`1-124`	`-16.100`	`12`	`PF11794.3; A3K7D3_9RHOB/13-275; 4-hydroxyphenylacetate 3-hydroxylase N terminal`
				`144-300`	`-29.300`	`17`	`PF00441.19; O33331_MYCTU/253-403; Acyl-CoA dehydrogenase, C-terminal domain`
8	`sp\|O15254\|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens GN=ACOX3 PE=1 SV=2 (Range:301-600)`	`300`	`PfamA26U`	`1-166`	`-34.200`	`19`	`PF00441.19; O33331_MYCTU/253-403; Acyl-CoA dehydrogenase, C-terminal domain`
				`210-300`	`-21.900`	`15`	`PF01756.14; O62140_CAEEL/484-669; Acyl-CoA oxidase`
9	`sp\|O15254\|ACOX3_HUMAN Peroxisomal acyl-coenzyme A oxidase 3 OS=Homo sapiens GN=ACOX3 PE=1 SV=2 (Range:451-700)`	`250`	`PfamA26U`	`60-246`	`-69.400`	`18`	`PF01756.14; O62140_CAEEL/484-669; Acyl-CoA oxidase`
10	`sp\|Q9H013\|ADA19_HUMAN(removed signalp:1-25) Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 (Range:1-300)`	`300`	`PfamA26U`	`2-137`	`-51.700`	`23`	`PF01562.14; ATS3_HUMAN/42-201; Reprolysin family propeptide`
				`185-300`	`-55.800`	`24`	`PF01421.14; ADAM2_BOVIN/178-375; Reprolysin (M12B) family zinc metalloprotease`
11	`sp\|Q9H013\|ADA19_HUMAN(removed signalp:1-25) Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 (Range:151-450)`	`300`	`PfamA26U`	`35-233`	`-78.900`	`24`	`PF01421.14; ADAM2_BOVIN/178-375; Reprolysin (M12B) family zinc metalloprotease`
				`250-300`	`-23.000`	`45`	`PF00200.18; ADA32_HUMAN/400-477; Disintegrin`
12	`sp\|Q9H013\|ADA19_HUMAN(removed signalp:1-25) Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 (Range:301-600)`	`300`	`PfamA26U`	`1-83`	`-29.600`	`22`	`PF01421.14; ADAM2_BOVIN/178-375; Reprolysin (M12B) family zinc metalloprotease`
				`100-175`	`-30.300`	`42`	`PF00200.18; ADA32_HUMAN/400-477; Disintegrin`
				`177-294`	`-37.300`	`25`	`PF08516.7; ADAM2_MACFA/473-589; ADAM cysteine-rich`
13	`sp\|Q9H013\|ADA19_HUMAN(removed signalp:1-25) Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 (Range:451-750)`	`300`	`PfamA26U`	`1-254`	`-11.600`	`15`	`PF07243.6; GP_PTPV/282-808; Phlebovirus glycoprotein G1`
				`27-142`	`-26.400`	`25`	`PF08516.7; ADAM2_MACFA/473-589; ADAM cysteine-rich`
				`38-241`	`-13.200`	`12`	`PF06247.6; Q968Z9_9APIC/23-221; Plasmodium ookinete surface protein Pvs28`
				`137-300`	`-11.600`	`16`	`PF13908.1; Q6DC69_DANRE/23-231; Wnt and FGF inhibitory regulator`
				`152-206`	`-13.900`	`21`	`PF01414.14; JAG2_RAT/132-194; Delta serrate ligand`
14	`sp\|Q9H013\|ADA19_HUMAN(removed signalp:1-25) Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 (Range:601-900)`	`300`	`PfamA26U`	`4-48`	`-11.600`	`20`	`PF04885.8; Q40579_TOBAC/7-146; Stigma-specific protein, Stig1`
				`31-299`	`-11.000`	`10`	`PF00513.13; VL2_HPV56/5-455; Late Protein L2`
				`82-300`	`-14.100`	`8`	`PF05934.6; CLCC1_HUMAN/3-551; Mid-1-related chloride channel (MCLC)`
15	`sp\|Q9H013\|ADA19_HUMAN(removed signalp:1-25) Disintegrin and metalloproteinase domain-containing protein 19 OS=Homo sapiens GN=ADAM19 PE=1 SV=3 (Range:751-930)`	`180`	`PfamA26U`	`1-180`	`-18.200`	`8`	`PF11725.3; A8E3E7_PSEVI/1-1719; Pathogenicity factor`
16	`sp\|P11766\|ADHX_HUMAN Alcohol dehydrogenase class-3 OS=Homo sapiens GN=ADH5 PE=1 SV=4`	`374`	`PfamA26U`	`32-160`	`-35.300`	`23`	`PF08240.7; Q92UI4_RHIME/24-130; Alcohol dehydrogenase GroES-like domain`
				`202-333`	`-27.400`	`21`	`PF00107.21; ADH_SULSO/182-311; Zinc-binding dehydrogenase`
17	`sp\|Q99490\|AGAP2_HUMAN Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 (Range:1-300)`	`300`	`PfamA26U`	`1-207`	`-13.600`	`11`	`PF05782.6; ECM1_HUMAN/1-540; Extracellular matrix protein 1 (ECM1)`
				`2-300`	`-13.300`	`9`	`PF03344.10; A7KII2_SALSA/6-727; Daxx Family`
18	`sp\|Q99490\|AGAP2_HUMAN Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 (Range:151-450)`	`300`	`PfamA26U`	`5-295`	`-11.400`	`12`	`PF11725.3; A8E3E7_PSEVI/1-1719; Pathogenicity factor`
				`9-213`	`-11.800`	`9`	`PF05782.6; ECM1_HUMAN/1-540; Extracellular matrix protein 1 (ECM1)`
19	`sp\|Q99490\|AGAP2_HUMAN Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 (Range:301-600)`	`300`	`PfamA26U`	`62-274`	`-16.100`	`10`	`PF05783.6; Q561T1_DANRE/5-493; Dynein light intermediate chain (DLIC)`
				`108-268`	`-54.400`	`28`	`PF00071.17; RAB9A_CANFA/9-174; Ras family`
20	`sp\|Q99490\|AGAP2_HUMAN Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 2 OS=Homo sapiens GN=AGAP2 PE=1 SV=2 (Range:451-750)`	`300`	`PfamA26U`	`1-118`	`-44.600`	`25`	`PF00071.17; RAB9A_CANFA/9-174; Ras family`
				`183-284`	`-9.890`	`10`	`PF00373.13; Q4T8R8_TETNG/88-414; FERM central domain`